NCT04485221 is a clinical trial in TECPR2, sponsored by University of Florida.

Who is sponsoring NCT04485221?

NCT04485221 is sponsored by University of Florida.

Is NCT04485221 still recruiting?

NCT04485221 is currently completed. Last updated 11 September 2023.

Last reviewed 2023-09-11 · How we verify

NCT04485221

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

TECPR2 Observational Study

Completed Last updated 11 September 2023

What this trial tests

trial in TECPR2 in 5 participants. Completed in 17 August 2023.

Timeline

20 January 2021

Primary endpoint
17 August 2023

17 August 2023

Quick facts

Lead sponsor	University of Florida
Status	Completed
Study type	OBSERVATIONAL
Enrollment	5
Start date	20 January 2021
Primary completion	17 August 2023
Estimated completion	17 August 2023
Sites	1 location across United States

Conditions studied

TECPR2 — all drugs for TECPR2 →

Sponsor

University of Florida

Who can join

Adults 18 Months to 12, any sex, with TECPR2. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to learn more about the disease progression in patients with a TECPR2 mutation.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other University of Florida trials

Trials by the same sponsor.

NCT03429413 — Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial · NA · not yet recruiting
NCT06127550 — taVNS for Letter Learning in Dyslexia · NA · suspended
NCT07507214 — Optimized, Neuroplasticity-Enhanced-Depression (ONE-D) Transcranial Magnetic Stimulation (TMS) Treatment for Female Athl · Phase 2, PHASE3 · not yet recruiting
NCT07492316 — RNA-lipid Particle (RNA-LP) Vaccines for Recurrent/Progressive Medulloblastoma (MB) · Phase 1 · not yet recruiting
NCT06670794 — Using Ecological Momentary Data to Inform a Web Intervention for Romantic Partners Concerned About Their Loved Ones' Dri · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04485221 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Florida
Last refreshed: 11 September 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04485221.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing